 |
인쇄하기
취소
|
Shinpoon Pharm and WHO to jointly develop anti-malarial drug
Shinpoong Pharm announced on July 9 that it will jointly develop a novel anti-malarial drug in a tablet form until 2004 with the World Health Organization (WHO).
To that end, Shinpoong Pharm is to receive a $11.92 million grant from the MNV Foundation of Chairman Bill Gates, Microsoft of the U.S., to develop new treatments and preventive measures for malaria and it will sign an research fun...
To that end, Shinpoong Pharm is to receive a $11.92 million grant from the MNV Foundation of Chairman Bill Gates, Microsoft of the U.S., to develop new treatments and preventive measures for malaria and it will sign an research fun...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.